Cargando…
Tumor Killing by CD4(+) T Cells Is Mediated via Induction of Inducible Nitric Oxide Synthase-Dependent Macrophage Cytotoxicity
CD4(+) T cells can induce potent anti-tumor immune responses. Due to the lack of MHC class II expression in most cancer cells, antigen recognition occurs indirectly via uptake and presentation on tumor-infiltrating antigen-presenting cells (APCs). Activation of the APCs can induce tumor rejection, b...
Autores principales: | Fauskanger, Marte, Haabeth, Ole Audun Werner, Skjeldal, Frode Miltzow, Bogen, Bjarne, Tveita, Anders Aune |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064871/ https://www.ncbi.nlm.nih.gov/pubmed/30083157 http://dx.doi.org/10.3389/fimmu.2018.01684 |
Ejemplares similares
-
Tumor-specific CD4(+) T cells eradicate myeloma cells genetically deficient in MHC class II display
por: Tveita, Anders, et al.
Publicado: (2016) -
How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
por: Haabeth, Ole Audun Werner, et al.
Publicado: (2014) -
A model for cancer-suppressive inflammation
por: Haabeth, Ole Audun Werner, et al.
Publicado: (2012) -
B cell receptor ligation induces display of V-region peptides on MHC class II molecules to T cells
por: Huszthy, Peter Csaba, et al.
Publicado: (2019) -
Molecular profiling of tumor-specific T(H)1 cells activated in vivo
por: Lorvik, Kristina Berg, et al.
Publicado: (2013)